Yahoo Finance Today's Research Reports on Trending Tickers: Amicus Therapeutics and Intercept Pharmaceuticals
NEW YORK, NY / ACCESSWIRE / September 10, 2018 / Wall Street plunged on Friday after the Trump administration announced tariffs on another $267 billion worth of Chinese goods, pressuring the S&P 500 and Nasdaq to close down for the fourth consecutive session. The Dow Jones Industrial Average declined 0.31 percent to close at 25,916.54, while the S&P 500 Index decreased 0.22 percent to close at 2,871.68. The Nasdaq Composite Index fell 0.25 percent to close at 7,902.54. For the week Nasdaq slumped 2.6 percent, while Dow Jones and S&P 500 shed 0.2 percent and 1.0 percent, respectively.
“The tech weakness and trade do concern me to a degree. You don’t have a good market if tech isn’t a leader, and there’s no doubt that tariffs and weakness in China could become a bigger concern if the issue starts to spill out over into the U.S. more,” said Wayne Kaufman, Phoenix Financial Services’ chief market analyst.
RDI Initiates Coverage on:
Amicus Therapeutics, Inc.
https://rdinvesting.com/news/?ticker=FOLD
Intercept Pharmaceuticals, Inc.
https://rdinvesting.com/news/?ticker=ICPT
Amicus Therapeutics' stock jumped 3.14% Friday, to close the day at $12.50. The stock recorded a trading volume of 2,625,807 shares, which was above its three months average volume of 1,913,231 shares. In the last year, Amicus Therapeutics' shares have traded in a range of 11.92 - 17.62. The share price has gained 4.87% from its 52 week low. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $14.03 is below its 200-day moving average of $14.85. Shares of Amicus Therapeutics have fallen roughly 17.27 percent in the past month and are down 13.13 percent year-to-date.
Access RDI's Amicus Therapeutics, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=FOLD
On Friday, shares of Intercept Pharmaceuticals recorded a trading volume of 281,467 shares, which was below the three months average volume of 597,119 shares. The stock ended the day 3.76% higher at $112.33. The share price has fallen 5.49% from its 52 week high with a 52 week trading range of 51.05 - 118.85. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $104.74 is above its 200-day moving average of $80.99. Shares of Intercept Pharmaceuticals have fallen roughly 1.96 percent in the past month and are up 92.28 percent year-to-date.
Access RDI's Intercept Pharmaceuticals, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=ICPT
Our Actionable Research on Amicus Therapeutics, Inc. (NYSE:FOLD) and Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) can be downloaded free of charge at Research Driven Investing.
Research Driven Investing
We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.
RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.
Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.
CONTACT
For any questions, inquiries, or comments reach out to us directly at:
Address:
Email:
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE: RDInvesting.com
https://www.accesswire.com/511644/Todays-Research-Reports-on-Trending-Tickers-Amicus-Therapeutics-and-Intercept-Pharmaceuticals
